Robert McArthur

Title: The Innovations of Robert McArthur

Introduction

Robert McArthur is a notable inventor based in Kalamazoo, MI (US). He holds a total of 10 patents that reflect his significant contributions to the field of pharmacology. His work primarily focuses on developing treatments for various physiological and psychiatric conditions.

Latest Patents

Among his latest patents, McArthur has developed highly selective norepinephrine reuptake inhibitors. These methods and compositions are designed for treating humans suffering from, or preventing, physiological or psychiatric diseases, disorders, or conditions where inhibiting the reuptake of norepinephrine is beneficial. The compositions include compounds with a pharmacological selectivity of serotonin (K)/norepinephrine (K) of at least about 5000. Notable examples of such compounds include reboxetine, particularly the optically pure (S,S) enantiomer of reboxetine. The methods generally involve administering a therapeutic amount of these compositions. Additionally, he has disclosed methods for treating chronic fatigue syndrome, which include administering a therapeutic amount of racemic reboxetine or a pharmaceutically acceptable salt thereof to individuals suffering from this condition.

Career Highlights

Throughout his career, McArthur has worked with prominent companies such as Pharmacia & Upjohn Company and Pharmacia & Upjohn. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Erik H F Wong and Saeeduddin Ahmed. Their collaborative efforts have likely played a role in advancing McArthur's research and patent developments.

Conclusion

Robert McArthur's contributions to the field of pharmacology through his patents and innovative treatments have made a significant impact. His work continues to influence the development of therapies for various medical conditions.